Not yet recruiting NCT07522138
Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Home-based self-exercise feedback program using video.
- Who it may be relevant to
- Registry conditions: Home Exercise Program, PD - Parkinson's Disease, Feasibility Studies. Basic parameters: from 19 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study aims to test whether patients with Parkinson's disease can safely and effectively use a home-based exercise program guided by videos. Participants will follow video instructions for exercises at home while their movements are monitored by a camera, which provides real-time feedback. The study will check how well participants complete the exercises, their satisfaction with the program, and any changes in clinical function. The goal is to see if this type of home exercise can help patients increase their activity levels without significant side effects.
Interventions
- Behavioral Home-based self-exercise feedback program using video
Participants follow a 6-week home-based exercise program using video-guided instructions and the iPixel exercise feedback system, which monitors movements in real-time and provides corrective feedback. The program includes: Stretching exercises, Strength training, Balance exercises, Aerobic exercises, LSVT-specific exercises. Participants are instructed to complete sessions at least 5 times per week, 40 minutes per session. Additionally, weekly 30-minute in-person rehabilitation sessions are co
Primary outcome measures
- Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Part III (Motor Examination) [Time frame: From enrollment to the end of treatment at 6 weeks]
Secondary outcome measures (5)
- Modified Hoehn and Yahr sacle [Time frame: From enrollment to the end of treatment at 6 weeks]
- Berg Balance Scale [Time frame: From enrollment to the end of treatment at 6 weeks]
- Functional Gait Ability [Time frame: From enrollment to the end of treatment at 6 weeks]
- Freezing of Gait Questionnaire [Time frame: From enrollment to the end of treatment at 6 weeks]
- EuroQol-5 Dimention Questionnaire [Time frame: From enrollment to the end of treatment at 6 weeks]
Eligibility criteria
Inclusion criteria
- Adults aged 19 years or older, clinically diagnosed with Idiopathic Parkinson's Disease (PD) according to the Movement Disorder Society (MDS) clinical diagnostic criteria
- Patients at Hoehn and Yahr stage 1-2.5
- Patients on stable dopaminergic therapy with no changes in the past 1 month
- Patients receiving Lee Silverman Voice Treatment (LSVT) rehabilitation therapy once weekly as outpatients
- Patients who have voluntarily provided informed consent to participate in the study
Exclusion criteria
- Patients diagnosed with atypical parkinsonism
- Patients with musculoskeletal problems that make participation in rehabilitation difficult
- Patients who have limited access to the video-based home exercise feedback program
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
South Korea · 1 center
- Seoul National University Bundang Hospital — Seongnam-si
Publications
- Colon-Semenza C, Latham NK, Quintiliani LM, Ellis TD. Peer Coaching Through mHealth Targeting Physical Activity in People With Parkinson Disease: Feasibility Study. JMIR Mhealth Uhealth. 2018 Feb 15;6(2):e42. doi: 10.2196/mhealth.8074. PMID 29449201
- van Nimwegen M, Speelman AD, Hofman-van Rossum EJ, Overeem S, Deeg DJ, Borm GF, van der Horst MH, Bloem BR, Munneke M. Physical inactivity in Parkinson's disease. J Neurol. 2011 Dec;258(12):2214-21. doi: 10.1007/s00415-011-6097-7. Epub 2011 May 26. PMID 21614433
- Politis M, Wu K, Molloy S, G Bain P, Chaudhuri KR, Piccini P. Parkinson's disease symptoms: the patient's perspective. Mov Disord. 2010 Aug 15;25(11):1646-51. doi: 10.1002/mds.23135. PMID 20629164
- Fox SH, Luca DG, Postuma RB, Bhidayasiri R, Cardoso F, Kovacs GG, Katzenschlager R, Trenkwalder C. Revisiting the 2015 MDS diagnostic criteria for Parkinson disease: insights from autopsy-confirmed cases. NPJ Parkinsons Dis. 2025 Dec 13;11(1):360. doi: 10.1038/s41531-025-01206-6. PMID 41390531
Identifiers
NCT: NCT07522138 · B-2602-1027-304 · B-2602-1027-304